CERO THERAPEUTICS
CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.
CERO THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2017-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.cero.bio
Total Employee:
1+
Status:
Active
Total Funding:
41.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Sitelinks Search Box Amazon Yoast WordPress SEO Plugin Google Maps
Similar Organizations
AffyXell Therapeutics
AffyXell Therapeutics develops novel mesenchymal stem cell therapies.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Atara Biotherapeutics
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Avammune Therapeutics
Avammune Therapeutics is a drug discovery company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Central European Research Centre
CERC is a Hungarian R&D company.
Curamir Therapeutics
Curamir Therapeutics is a developer of miRNA-based cancer therapeutics.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
IMPACT Therapeutics
IMPACT Therapeutics is a China based Company.
IMVAQ Therapeutics
Imvaq Therapeutics is an innovative cancer immunotherapy company.
Lacerta Therapeutics
Lacerta Therapeutics is a clinical stage gene therapy company.
Lunac Therapeutics
Lunac Therapeutics is a UK-based drug discovery company.
Macomics
Macomics is an immuno-oncology company.
Modulus Therapeutics
Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.
Orthogon Therapeutics
Orthogon Therapeutics is a drug development company.
ProfoundBio
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
Caraway Therapeutics
Rheostat Therapeutics is a bio therapeutics company.
Stemson Therapeutics
Stemson Therapeutics is a pre-clinical stage cell therapy company.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Xios Therapeutics
Xios Therapeutics is a biotechnology company .
Current Employees Featured
Founder
Investors List
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series A - Cero Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Cero Therapeutics
Sequoia Capital China
Sequoia Capital China investment in Series A - Cero Therapeutics
Lyell Immunopharma
Lyell Immunopharma investment in Series A - Cero Therapeutics
Official Site Inspections
http://www.cero.bio
- Host name: 123.217.117.34.bc.googleusercontent.com
- IP address: 34.117.217.123
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cero Therapeutics"
Cero | Home
Tumor cell clearance reimagined. Our mission is to discover, translate, and deliver pioneering curative cell therapies that incorporate multiple forms of tumor clearance into single T cells.See details»
Cero Therapeutics - Crunchbase Company Profile
CERo Therapeutics, Inc. is a new cellular immunotherapy company. GlobeNewswire News Room โ CERo Therapeutics Holdings, Inc. Announces โฆSee details»
CERo Therapeutics Holdings, Inc. (CERo Therapeutics Holdings, Inc ...
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Cero Therapeutics Holdings, Inc., (NASDAQ:CERO) (โCERoโ) an innovative immunotherapy company seeking to โฆSee details»
CERo Therapeutics Holdings, Inc. - Drug pipelines, Patents
Contact: Brian Atwood Chief Executive Officer [email protected] Investors: CORE IR [email protected]. Immunotherapy Cell Therapy AACR. ... The statistics for drugs in the โฆSee details»
Home | CERO
The Coalition for the Ecological Recovery in Organics, or CERO, is a group of growers, independent companies, scientists, and environmental stewards who are focused on supporting the growing organic community in the U.S. and โฆSee details»
CERo Therapeutics Holdings, Inc. (CERO) - Yahoo Finance Canada
See the company profile for CERo Therapeutics Holdings, Inc. (CERO) including business summary, industry/sector information, number of employees, business summary, corporate โฆSee details»
Cero | Home
The CER platform. We are advancing a CER T-cell platform that potentially offers novel approaches for the treatment of both hematologic malignancies and solid tumors.See details»
Cero | Corporate Governance
Jan 25, 2024 Board Diversity Matrix as of January 25, 2024; Total Number of Directors: Gender Identity Female Male Non-binary Did not disclose gender; Directors: 2: 3: Demographic BackgroundSee details»
CERo Therapeutics, Inc. (CERo Therapeutics, Inc.) - ่ฏ็ฉ โฆ
้กนไธ CERo Therapeutics, Inc. ็ธๅ ณ็ๆ็ฎ๏ผๅป่ฏ๏ผ 2024-05-01 · Clinical cancer research : an official journal of the American Association for Cancer Research Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid โฆSee details»
CERo Therapeutics - Work in biotech
CERo Therapeutics is developing cellular immunotherapies to create a new class of cancer therapeutics using recent insights from synthetic and T cell biology. Receptor mediated cell โฆSee details»
CERo Therapeutics Holdings (CERO) Company Profile & Description
6 days ago CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its โฆSee details»
CERo Therapeutics Holdings, Inc. Announces Progress in
Mar 6, 2025 CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to โฆSee details»
Cero | Our Science
At CERo, we are integrating the most recent insights from synthetic and T cell biology to create a new generation of engineered T cells for treatment of cancer. Leveraging a natural immune โฆSee details»
CERo Therapeutics Holdings, Inc. (CERO) - Yahoo Finance
Find the latest CERo Therapeutics Holdings, Inc. (CERO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... , Inc. Announces โฆSee details»
CERO 3D Incubator and Bioreactor | Your Home for Cell Research
Suitable for a wide range of cell typesโincluding stem cells, tumor cells, and even tissue biopsiesโCERO 3D delivers high-quality 3D culture capabilities to labs of all sizes. With four โฆSee details»
Meet 3D CERO Incubator and Bioreactor | Your Home for Cell โฆ
The CERO 3D Incubator & Bioreactor is not just another tool in your lab; it's a game-changer for cell culture, setting new standards in precision, flexibility and scalability. This revolutionary โฆSee details»
Cero | Investor Relations
The company has significant operating losses, with a net loss of $7.3 million for 2023, an accumulated deficit of $43.1 million, and $1.6 million in cash. CERo expects continued net โฆSee details»
CERo Therapeutics Holdings, Inc. (CERO) Stock Price, News, Quote ...
Find the latest CERo Therapeutics Holdings, Inc. (CERO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... , Inc. Announces โฆSee details»
New survey: U.S. biotechs warn tariffs could impede access to โฆ
2 days ago WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the โฆSee details»
Cero | CER Technology Platform
Therapeutic potential. CERo's platform provides a distinct approach to other immune-based therapies. The platform has the potential to recognize broad tumor types, and, by combining โฆSee details»